CVS Health Corporation’s stock price edged up in the intraday levels, amid the dominance of the upward correctional trend in the short term, with positive support from the 50-day SMA, countered with negative signals from the RSI after reaching overbought levels, hindering recent gains.
Therefore we expect more gains for the stock, targeting the pivotal resistance of 83.25, provided it settles above 76.60.
Stay updated on market developments for informed investment decisions.